Wave Life Sciences, Inc. (WVE)
3.78
-0.18
(-4.55%)
USD |
NASDAQ |
Sep 25, 16:00
3.765
-0.02
(-0.40%)
After-Hours: 19:59
Wave Life Sciences Price to Book Value : 1.611 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 1.611 |
| September 24, 2026 | 1.688 |
| September 23, 2026 | 1.683 |
| September 22, 2026 | 1.854 |
| September 21, 2026 | 1.813 |
| September 18, 2026 | 1.854 |
| September 17, 2026 | 1.892 |
| September 16, 2026 | 1.920 |
| September 15, 2026 | 1.901 |
| September 14, 2026 | 1.952 |
| September 11, 2026 | 1.956 |
| September 10, 2026 | 1.990 |
| September 09, 2026 | 2.050 |
| September 08, 2026 | 2.092 |
| September 04, 2026 | 2.071 |
| September 03, 2026 | 2.003 |
| September 02, 2026 | 2.080 |
| September 01, 2026 | 2.118 |
| August 31, 2026 | 2.088 |
| August 28, 2026 | 2.148 |
| August 27, 2026 | 2.199 |
| August 26, 2026 | 2.229 |
| August 25, 2026 | 2.237 |
| August 24, 2026 | 2.182 |
| August 21, 2026 | 2.254 |
| Date | Value |
|---|---|
| August 20, 2026 | 2.237 |
| August 19, 2026 | 2.308 |
| August 18, 2026 | 2.254 |
| August 17, 2026 | 2.169 |
| August 14, 2026 | 2.306 |
| August 13, 2026 | 2.216 |
| August 12, 2026 | 2.233 |
| August 11, 2026 | 2.15 |
| August 10, 2026 | 2.587 |
| August 07, 2026 | 2.600 |
| August 06, 2026 | 2.566 |
| August 05, 2026 | 2.527 |
| August 04, 2026 | 2.557 |
| August 03, 2026 | 2.446 |
| July 31, 2026 | 2.348 |
| July 30, 2026 | 2.455 |
| July 29, 2026 | 2.476 |
| July 28, 2026 | 2.510 |
| July 27, 2026 | 2.523 |
| July 24, 2026 | 2.476 |
| July 23, 2026 | 2.463 |
| July 22, 2026 | 2.446 |
| July 21, 2026 | 2.468 |
| July 20, 2026 | 2.442 |
| July 17, 2026 | 2.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.5681 |
| CorMedix, Inc. | 1.323 |
| Eloxx Pharmaceuticals, Inc. | 1.307 |
| Breakthrough Chemistry, Inc. | 2.044 |
| BioStem Technologies, Inc. | 2.672 |
Price to Book Value Related Metrics
| PS Ratio | 10.87 |
| PEG Ratio | -0.16 |
| Price | 3.78 |
| Earnings Yield | -28.74% |
| Market Cap | 730.59M |
| PEGY Ratio | -0.16 |